Navigation Links
NeurogesX Reports First Quarter 2009 Results
Date:5/7/2009

(2) General and administrative 248 201 ---- ---- $507 $399 ==== ====


                                     NEUROGESX, INC.
                              (A Development Stage Company)

                          CONDENSED CONSOLIDATED BALANCE SHEETS
                                     (in thousands)



                                                     March 31,   December 31,
                                                        2009        2008
                                                     ---------   -----------
                                                    (unaudited)      (1)
                                                    -----------  -----------
                           Assets
     Current assets:
       Cash and cash equivalents                       $6,561     $10,435
       Short-term investments                          12,286      14,071
       Prepaid expenses and other current assets          362         412
       Restricted cash                                     40          40
                                                       ------     -------
     Total current assets                              19,249      24,958
     Property and equipment, net                          420         468
     Restricted cash                                      160         160
     Other assets                                          --           4
                                                      -------     -------
     Total assets                                     $19,829     $25,590
                                                      =======     =======
            Liabilities and Stockholders' Equity
     Current liabilities:
       Accounts payable  
'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
2. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
3. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
4. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
5. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
6. NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference
7. NeurogesX Reports Third Quarter 2008 Results
8. NeurogesX to Report Third Quarter 2008 Financial Results
9. NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
10. NeurogesX Responds to EMEAs Day 120 Questions
11. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... SEGUNDO, Calif. , July 30, 2014 /PRNewswire/ ... contractor on the Fully Integrated Lifecycle Mission Support ... and Space Administration (NASA). Under the terms of ... Ames Research Center at Moffett Field, Calif. In ... support for bioscience flight development projects on the ...
(Date:7/30/2014)... July 30, 2014. Applied DNA ... that provides DNA-based authentication and security solutions and services, ... of Life Sciences, a newly created position, with a ... will lead APDN’s drive to build its business in ... healthcare customers, provide guidance to APDN’s R&D efforts, and ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Vycom announces ... of products, designed to meet Factory Mutual (FM) 4910 ... materials such as wet benches, process tools, fume hoods, ... safety and damage to semiconductor wafers used in electronic ... a flame-retardant PVC solution with excellent workability and superior ...
(Date:7/30/2014)... , July 30, 2014  Orexigen Therapeutics, Inc. (Nasdaq: ... the Day 180 List of Outstanding Issues (LOI) from ... Human Use (CHMP) for the NB32 Marketing Authorization Application ... is an investigational drug candidate being evaluated for weight ... Day 120 time point were adequately addressed by the ...
Breaking Biology Technology:Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Immunodiagnostics Markets: US, Europe, Japan Product ... for Instrumentand Reagent Suppliers ...
... 25, 2011 Practice Fusion , the ... working with Microsoft,s DataMarket on the Windows Azure Marketplace ... developers and researchers is part of the Health 2.0 ... Developer Challenge with the support of the Chief Technology ...
... Jan. 25, 2011 Reportlinker.com announces that ... in its catalogue: Future ... of Emerging Reimbursement, Technological and Market Trends ... How will the ...
Cached Biology Technology:Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan Product Development Opportunities and Business Expansion Strategies for Instrumentand Reagent Suppliers 2Practice Fusion Invites Health Researchers to 'Analyze This!' Contest on Windows Azure 2Practice Fusion Invites Health Researchers to 'Analyze This!' Contest on Windows Azure 3Reportlinker Adds Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends Through 2018 2
(Date:7/30/2014)... infection could be as simple as inserting a medicated, ... of Washington bioengineers have discovered a potentially faster way ... contracting HIV. Their method spins the drug into silk-like ... releasing higher doses of the drug than possible with ... "This could offer women a potentially more effective, discreet ...
(Date:7/30/2014)... climate threaten some of the world,s most rare ... seed collections to save the seeds in banks ... genetic diversity., For decades, these seed collections have ... one-size-fits-all approach for how many seeds to gather, ... of species, pollination mode, growth habitat and population ...
(Date:7/30/2014)... Americans make better decisions about what they eat, the ... significant changes to the Nutrition Facts label found on ... in Chemical & Engineering News (C&EN), the ... the suggested updates and the fight that has ... points out that while the Nutrition Facts label has ...
Breaking Biology News(10 mins):Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3Saving seeds the right way can save the world's plants 2
... have charted the path of insulin action in cells in ... for understanding what goes wrong in diabetes. The ... from Sydney,s Garvan Institute of Medical Research, is now published ... Cell Metabolism . First discovered in 1921, the insulin ...
... (MAY 20, 2013) University of Minnesota Medical School ... in partnership with the University,s Brain Tumor Program, have ... sheath tumors (MPNST) that allow them to discover new ... The research was published this week in the ...
... A National Science Foundation (NSF) planning grant will help ... a joint program of the University of Illinois at ... "CARD will be devoted to research in drying ... products; forestry and paper products; chemical products; textiles; and ...
Cached Biology News:Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2
... ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 H 15 ... ,M.W.= 408.63 ,Assay: Greater than ... DMF) ,Biological Activity: Blue color with ... Agrees with theoretical values ,Thin Layer ...
Immunochemistry 1 & 2...
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Biology Products: